Abstract
Saffron is an integral part of various traditional medicines containing several phytochemicals having disease preventing and health promoting properties. The antidepressant, cardio protective and chemopreventive properties of saffron can be attributed to its constinuent active phytochemicals and bioactive compounds like crocin, crocetin and safranal. Publicly available databases like NCBI-PubChem and ChEMBL have millions of bioactive compounds.This offers opportunity to mine the compound(s) of interest based on desired attributes in the therapeutic area of interest. The current review, attempts to identify potential of molecular basis of bioactive compounds of saffron.
Keywords: Active components, Crocus sativus L., saffron, toxicity.
Graphical Abstract
The Natural Products Journal
Title:Therapeutic Applications of Crocus sativus L. (Saffron): A Review
Volume: 6 Issue: 3
Author(s): Maryam Vahedi, Sumit Govil, Shailesh Kumar, Divya Shrivastava, Roghaye Karimi and Prakash S. Bisen
Affiliation:
Keywords: Active components, Crocus sativus L., saffron, toxicity.
Abstract: Saffron is an integral part of various traditional medicines containing several phytochemicals having disease preventing and health promoting properties. The antidepressant, cardio protective and chemopreventive properties of saffron can be attributed to its constinuent active phytochemicals and bioactive compounds like crocin, crocetin and safranal. Publicly available databases like NCBI-PubChem and ChEMBL have millions of bioactive compounds.This offers opportunity to mine the compound(s) of interest based on desired attributes in the therapeutic area of interest. The current review, attempts to identify potential of molecular basis of bioactive compounds of saffron.
Export Options
About this article
Cite this article as:
Vahedi Maryam, Govil Sumit, Kumar Shailesh, Shrivastava Divya, Karimi Roghaye and Bisen S. Prakash, Therapeutic Applications of Crocus sativus L. (Saffron): A Review, The Natural Products Journal 2016; 6 (3) . https://dx.doi.org/10.2174/2210315506666160502112533
DOI https://dx.doi.org/10.2174/2210315506666160502112533 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry Dinuclear Berenil-Platinum (II) Complexes as Modulators of Apoptosis in Human MCF-7 and MDA-MB231 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry 1-O-Octadecyl-2-O-Methylglycero-3-phosphocholine (Edelfosine) and Cancer Cell Invasion: A Short Review
Anti-Cancer Agents in Medicinal Chemistry Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design Papillary Thyroid Carcinoma in Pediatric Age: An Example of a Rare Tumour Managed Within a Cooperative Comprehensive Project
Current Pediatric Reviews ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Current Medicinal Chemistry - Anti-Cancer Agents Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
Current Cancer Drug Targets microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design DNA Binding Mode of Transition Metal Complexes, A Relationship to Tumor Cell Toxicity
Current Medicinal Chemistry Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEXDC<sup>®</sup>) in the Palliative Treatment of Pancreatic Cancer
Current Medicinal Chemistry Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview
Current Drug Targets